Trade OMER anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Omeros Corporation (OMER) is trading at US$18.95, down 0.84% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$1.39B. Over the past 52 weeks, OMER has traded between US$3.94 and US$19.65. On Syfe you can trade OMER with $0 commission and add it to your watchlist.
| Previous close | US$19.11 |
|---|---|
| Market cap | US$1.39B |
| P/E ratio | 19.65 |
| 52-week range | US$3.94 – US$19.65 |
| Volume | 838.52K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Omeros Corporation
Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
Year: 2009
Omeros Corporation (OMER) stock is trading at US$18.95, -0.84% from the previous close of US$19.11.
The market cap for Omeros Corporation (OMER) stock is approximately US$1.39B.
The price-to-earnings ratio for Omeros Corporation (OMER) is 19.65, based on the latest reported earnings.
The 52-week high for Omeros Corporation (OMER) stock is US$19.65.
The 52-week low for Omeros Corporation (OMER) stock is US$3.94.
Omeros Corporation (OMER) does not currently pay a dividend.
Stay on top of OMER
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
